Seagen concluded the agreement with RemeGen on 2,6 billion dollars on development anticarcinogenic preparations

@Farmatsevticheskij vestnik
#Large business#Economics.Other
Show original
Companies will develop means under the name disitamab...
Full text at the source
Analysis
×
Organizations
Organization Ranking
Places
Place ranking
921
921